You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
How IQVIA’s unchecked growth could come to a halt
Health data giant IQVIA’s unbridled growth might come to a halt as regulators begin to rein in its acquisitions, Casey Ross writes. A Federal Trade Commission lawsuit aims to block IQVIA’s plan to scoop up digital advertising company DeepIntent, and argues that the scope and sprawl of the company’s data could lead to a deluge of ads targeting patients and doctors.
About the Author Reprints
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let's stay connected!
To submit a correction request, please visit our Contact Us page.